- Home
- FMC vs PLXS Comparison
FMC vs PLXS Comparison
Compare FMC & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMC | PLXS |
|---|---|---|
| Founded | 1910 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Electrical Products |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.0B |
| IPO Year | N/A | 1986 |
Fundamental Metrics
Financial Performance| Metric | FMC | PLXS |
|---|---|---|
| Price | $13.42 | $154.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | $24.08 | ★ $160.00 |
| AVG Volume (30 Days) | ★ 4.4M | 210.1K |
| Earning Date | 02-04-2026 | 01-21-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 6.26 |
| Revenue | $3,608,400,000.00 | ★ $4,032,966,000.00 |
| Revenue This Year | N/A | $10.99 |
| Revenue Next Year | $2.61 | $7.02 |
| P/E Ratio | ★ N/A | $24.60 |
| Revenue Growth | N/A | ★ 1.82 |
| 52 Week Low | $12.17 | $103.43 |
| 52 Week High | $57.00 | $172.89 |
Technical Indicators
Market Signals| Indicator | FMC | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.65 | 55.00 |
| Support Level | $12.95 | $151.94 |
| Resistance Level | $14.15 | $156.41 |
| Average True Range (ATR) | 0.57 | 5.37 |
| MACD | 0.34 | -0.51 |
| Stochastic Oscillator | 35.24 | 33.73 |
Price Performance
Historical ComparisonAbout FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.